• Academy Events

  • Targeting Tau in Alzheimer's Disease and Related Disorders

    Monday, March 13, 2017 | 9:00 AM - 4:45 PM
    The New York Academy of Sciences

    Presented by the Brain Dysfunction Discussion Group

      • Registration Closed

    The microtubule associated protein tau (MAPT) is a key mediator of neurodegeneration in Alzheimer’s disease and related disorders. This symposium will address the potential of tau-related targets for immunotherapy, across the spectrum of tauopathies. We will review the pre-clinical and clinical development of several tau immunotherapy programs that exemplify this emerging therapeutic strategy for Alzheimer’s disease and other devastating neurodegenerative disorders.

    Reception to follow.

    Registration Pricing

    Member $60
    Member (Student / Postdoc / Resident / Fellow) $25
    Nonmember (Academia) $105
    Nonmember (Corporate) $160
    Nonmember (Non-profit) $105
    Nonmember (Student / Postdoc / Resident / Fellow) $70

    This event will also be broadcast as a webinar; registration is required.

    Please note: Transmission of presentations via the webinar is subject to individual consent by the speakers. Therefore, we cannot guarantee that every speaker's presentation will be broadcast in full via the webinar. To access all speakers' presentations in full, we invite you to attend the live event in New York City where possible.

    Webinar Pricing

    Member $30
    Member (Student / Postdoc / Fellow) $15
    Nonmember (Academia) $65
    Nonmember (Corporate) $85
    Nonmember (Non-profit) $65
    Nonmember (Student / Postdoc / Fellow) $45


    The Brain Dysfunction Discussion Group is proudly supported by

    • Acorda Therapeutics